Long-term storage and safe retrieval of human papillomavirus DNA using FTA elute cards

Journal of Virological Methods

Volumn 229, Issue , 2016, Pages 60-65

  Barth, Heidi ^a   Morel, Adrien ^b   Mougin, Christiane ^b   Averous, Gerlinde ^c   Legrain, Michèle ^c   Fender, Muriel ^d   Risch, Simone ^a   Fafi Kremer, Samira ^a   Velten, Michel ^e   Oudet, Pierre ^c   Baldauf, Jean Jacques ^b,c   Stoll Keller, Françoise ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d EVE Association   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Biobanking; Cervical cancer; Papillomavirus; Storage of cells

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BIOSAFETY; CONTROLLED STUDY; DNA EXTRACTION; ELUTE CARD; ENVIRONMENTAL TEMPERATURE; FEMALE; GENOTYPING TECHNIQUE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 35; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; STORAGE; VIRUS DETECTION; VIRUS LOAD; WART VIRUS; CYTOLOGY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRESERVATION; PROCEDURES; RETROSPECTIVE STUDY; SPECIMEN HANDLING; UTERINE CERVIX; VIROLOGY; YOUNG ADULT;

ADULT; AGED; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRESERVATION, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SPECIMEN HANDLING; VIROLOGY; YOUNG ADULT;

EID: 84953455327     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.12.010     Document Type: Article

References (36)

1. Abdelwhab E.M., Lüschow D., Harder T.C., Hafez H.M. The use of FTA® filter papers for diagnosis of avian influenza virus. J. Virol. Methods 2011, 174:120-122.
2. Agreda P.M., Beitman G.H., Gutierrez E.C., Harris J.M., Koch K.R., LaViers W.D., Leitch S.V., Maus C.E., McMillian R.A., Nussbaumer W.A., Palmer M.L., Porter M.J., Richart G.A., Schwab R.J., Vaughan L.M. Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media. J. Clin. Microbiol. 2013, 51:2702-2706.
3. Bonde J., Rebolj M., Ejegod D.M., Preisler S., Lynge E., Rygaard C. HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system. BMC Infect. Dis. 2014, 14:413.
4. Castle P.E., Solomon D., Hildesheim A., Herrero R., Concepcion Bratti M., Sherman M.E., Cecilia Rodriguez A., Alfaro M., Hutchinson M.L., Terence Dunn S., Kuypers J., Schiffman M. Stability of archived liquid-based cervical cytologic specimens. Cancer Cytopathol. 2003, 99:89-96.
5. Chaturvedi A.K., Katki H.A., Hildesheim A., Rodríguez A.C., Quint W., Schiffman M., Van Doorn L.-J., Porras C., Wacholder S., Gonzalez P., Sherman M.E., Herrero R., Group F.T.C. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J. Infect. Dis. 2011, 203:910-920.
6. da Cunha Santos G., Liu N., Tsao M.-S., Kamel-Reid S., Chin K., Geddie W.R. Detection of EGFR and KRAS mutations in fine-needle aspirates stored on Whatman FTA cards. Cancer Cytopathol. 2010, 118:450-456.
7. de Bie R.P., Schmeink C.E., Bakkers J.M.J.E., Snijders P.J.F., Quint W.G.V., Massuger L.F.A.G., Bekkers R.L.M., Melchers W.J.G. The indicating FTA elute cartridge: a solid sample sarrier to detect high-risk HPV and high-grade cervical lesions. J. Mol. Diagn. 2011, 13:371-376.
8. Devost N.C., Choy F.Y.M. Mutation analysis of Gaucher disease using dot-blood samples on FTA® filter paper. Am. J. Med. Genet. 2000, 94:417-420.
9. Dickson E.L., Vogel R.I., Bliss R.L., Downs L.S. Multiple-type HPV infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology. Int. J. Gynecol. Cancer 2013, 23. 10.1097/IGC.0b013e31829e9fb4.
10. Drolet M., Bénard É., Boily M.-C., Ali H., Baandrup L., Bauer H., Beddows S., Brisson J., Brotherton J.M.L., Cummings T., Donovan B., Fairley C.K., Flagg E.W., Johnson A.M., Kahn J.A., Kavanagh K., Kjaer S.K., Kliewer E.V., Lemieux-Mellouki P., Markowitz L., Mboup A., Mesher D., Niccolai L., Oliphant J., Pollock K.G., Soldan K., Sonnenberg P., Tabrizi S.N., Tanton C., Brisson M. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 2015, 15:565-580.
11. Fontaine D., Monnot S., Vandenbos F., Paquis P., Michiels J.F., Bannwarth S., Paquis-Flucklinger V. DNA extraction by FTA™ technology: application for rapid detection of 1p/19q deletions in gliomas. Neuropathol. Appl. Neurobiol. 2007, 33:360-363. The Nice Brain Tumor Study Group.
12. Geraets D.T., van Baars R., Alonso I., Ordi J., Torné A., Melchers W.J.G., Meijer C.J.L.M., Quint W.G.V. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge. J. Clin. Virol. 2013, 57:125-129.
13. Gonzalez P., Cortes B., Quint W., Kreimer A.R., Porras C., Rodriguez A.C., Jimenez S., Herrero R., Struijk L., Hildesheim A., Melchers W. Evaluation of the FTA carrier device for human papillomavirus testing in developing countries. J. Clin. Microbiol. 2012, 50:3870-3876.
14. Guan Y., Gravitt P.E., Howard R., Eby Y.J., Wang S., Li B., Feng C., Qiao Y.-L., Castle P.E. Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J. Virol. Methods 2013, 189:167-171.
15. Gustavsson I., Lindell M., Wilander E., Strand A., Gyllensten U. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J. Clin. Virol. 2009, 46:112-116.
16. Gustavsson I., Sanner K., Lindell M., Strand A., Olovsson M., Wikström I., Wilander E., Gyllensten U. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J. Clin. Virol. 2011, 51:255-258.
17. Gyllensten U., Gustavsson I., Lindell M., Wilander E. Primary high-risk HPV screening for cervical cancer in post-menopausal women. Gynecol. Oncol. 2012, 125:343-345.
18. He H., Argiro L., Dessein H., Chevillard C. Improved technique that allows the performance of large-scale SNP genotyping on DNA immobilized by FTA® technology. Infect. Genet. Evol. 2007, 7:128-132.
19. Hedman J., Albinsson L., Ansell C., Tapper H., Hansson O., Holgersson S., Ansell R. A fast analysis system for forensic DNA reference samples. Forensic Sci. Int. Genet. 2008, 2:184-189.
20. Kraus R.H.S., van Hooft P., Waldenström J., Latorre-Margalef N., Ydenberg R.C., Prins H.H.T. Avian influenza surveillance with FTA cards: field methods, biosafety, and transportation issues solved. J. Vis. Exp. 2011, 2832.
21. Lenselink C.H., de Bie R.P., van Hamont D., Bakkers J.M.J.E., Quint W.G.V., Massuger L.F.A.G., Bekkers R.L.M., Melchers W.J.G. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J. Clin. Microbiol. 2009, 47:2564-2570.
22. Li C.C., Beck I.A., Seidel K.D., Frenkel L.M. Persistence of human immunodeficiency virus type 1 subtype B DNA in dried-blood samples on FTA filter paper. J. Clin. Microbiol. 2004, 42:3847-3849.
23. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
24. Negri G., Rigo B., Vittadello F., Egarter-Vigl E., Mian C. Human papillomavirus typing with hybrid capture II on archived liquid-based cytologic specimens: is HPV typing always reproducible?. Am. J. Clin. Pathol. 2004, 122:90-93.
25. Pagano S., Sans M., Pimenoff V., Cantera A.M., Alvarez J.C., Lorente J.A., Peco J.M., Mones P., Sajantila A. Assessment of HV1 and HV2 mtDNA variation for forensic purposes in an Uruguayan population sample. J. Forensic Sci. 2005, 50:1239-1242.
26. Phongsavan K., Gustavsson I., Marions L., Phengsavanh A., Wahlström R., Gyllensten U. Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types. Int. J. Gynecol. Cancer 2012, 22:1398-1406.
27. Picard-Meyer E., Barrat J., Cliquet F. Use of filter paper (FTA®) technology for sampling, recovery and molecular characterisation of rabies viruses. J. Virol. Methods 2007, 140:174-182.
28. Powell N., Smith K., Fiander A. Recovery of human papillomavirus nucleic acids from liquid-based cytology media. J. Virol. Methods 2006, 137:58-62.
29. Pretet J.L., Jacquard A.C., Carcopino X., Charlot J.F., Bouhour D., Kantelip B., Soubeyrand B., Leocmach Y., Mougin C., Riethmuller D. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int. J. Cancer 2008, 122:428-432.
30. Rajendram D., Ayenza R., Holder F.M., Moran B., Long T., Shah H.N. Long-term storage and safe retrieval of DNA from microorganisms for molecular analysis using FTA matrix cards. J. Microbiol. Methods 2006, 67:582-592.
31. Rousseau M.-C., Villa L.L., Cecilia Costa M., Abrahamowicz M., Rohan T.E., Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex. Transm. Dis. 2003, 30:581-587.
32. Saieg M.A., Geddie W.R., Boerner S.L., Liu N., Tsao M., Zhang T., Kamel-Reid S., da Cunha Santos G. The use of FTA cards for preserving unfixed cytological material for high-throughput molecular analysis. Cancer Cytopathol. 2012, 120:206-214.
33. Saunier M., Monnier-Benoit S., Mauny F., Dalstein V., Briolat J., Riethmuller D., Kantelip B., Schwarz E., Mougin C., Prétet J.-L. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J. Clin. Microbiol. 2008, 46:3678-3685.
34. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907.
35. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., Franco E.L. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomark. Prev. 2006, 15:1274-1280.
36. Wang S.M., Hu S.Y., Chen F., Chen W., Zhao F.H., Zhang Y.Q., Ma X.M., Qiao Y.L. Clinical evaluation of human papillomavirus detection by careHPV test on physician-samples and self-samples using the indicating FTA Elute(R) card. Asian Pac. J. Cancer Prev. 2014, 15:7085-7089.